Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 91
Selected: 0
NCT IDTitle
NCT05524467Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients
NCT01131624Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
NCT01288651Iron Deficiency In Pulmonary Hypertension
NCT02147795The German Patient Blood Management Network
NCT03888066Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)
NCT00868439Evaluation of Patiromer in Heart Failure Patients
NCT04616092Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery
NCT00821717EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure
NCT04510792IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors
NCT03957187Prevalence and Clinical Associates of Iron Deficiency in Patients With Atrial Fibrillation
NCT05625542Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Hemodialysis Patients
NCT01513369Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency
NCT01245777Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy
NCT01464190A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients
NCT06434025IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency
NCT01477424A Drug-Drug Interaction Study of Warfarin and PA21
NCT01100879Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy
NCT05751772Improving Knowledge in Heart Failure Inpatient With Therapeutic Education
NCT01820949Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients
NCT02221752Impact of Iron/Folic Acid vs Folic Acid Supplements During Pregnancy on Maternal and Child Health
NCT04249648Hyperkalaemia and Its Impact on Therapy with RAASi
NCT03071263Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
NCT01452906A Drug-Drug Interaction Study of Omeprazole and PA21
NCT05897684Avacostar - (PASS)
NCT01810939A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)
NCT00520780Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)
NCT04903717Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists
NCT01371747Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)
NCT02213653Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency
NCT06593392Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
NCT05885737Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus
NCT03010072The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum
NCT05786469Patiromer Trial in CKD Stage IIIB to V
NCT01101399Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy
NCT01394562Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure
NCT06256991Potassium Correction for RAAS Optimization in Chronic Kidney Disease
NCT01975272The Use of Iron Therapy for Patients With Anemia After Caesarean Section
NCT01913808Comparing Intravenous and Oral Iron in Postoperative Anemia
NCT05885763Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on Haemodialysis
NCT01453608A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency
NCT05514951Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment
NCT01477411A Drug-Drug Interaction Study of Digoxin and PA21
NCT01438359A Drug-Drug Interaction Study of Furosemide and PA21
NCT03644264PA21 Safety and Efficacy in Adult Chinese Subjects
NCT05136664Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects
NCT04806048Feasibility of Implementation of Recommended Standards in Patients With Heart Failure
NCT05034250Iron Status in Female Infertility and Recurrent Miscarriage
NCT05415969CKD-aP Among Adults on Dialysis in Switzerland
NCT03781089Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients
NCT01130597Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease